Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 4, 1996, Pages 879-885

  Heisig, Peter ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE IV; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ALLELISM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; DRUG MECHANISM; ESCHERICHIA COLI; GENETIC ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; BASE SEQUENCE; CHROMOSOME MAPPING; CIPROFLOXACIN; DNA TOPOISOMERASE IV; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; MOLECULAR SEQUENCE DATA; NEISSERIA GONORRHOEAE; R FACTORS; SALMONELLA TYPHIMURIUM; SEQUENCE HOMOLOGY, AMINO ACID; STAPHYLOCOCCUS AUREUS;

EID: 0029986580     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.4.879     Document Type: Article

References (51)

1. Adams, D. E., B. M. Shekhtman, E. L. Zechiedrich, M. B. Schmid, and N. R. Cozzarelli. 1992, The role of topoisomerase IV in partitioning bacterial rephcons and the structure of catenated intermediates in DNA replication. Cell 71:277-288.
2. Appleyard, R. K. 1954. Segregation of lambda lysogenicity during bacterial recombination in Escherichia coli K-12. Genetics 39:429-439.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Stuhl. 1987. Current protocols in molecular biology. John Wiley & Sons Inc., New York.
4. Belland, R. J., S. G. Morrison, C. Ison, and W. M. Huang. 1994. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol. Microbiol. 14:371-380.
5. Cambau, E., F. Bordon, E. Collatz, and L. Gutmann. 1993. Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid. Antimicrob. Agents Chemother. 37:1247-1252.
6. Coheu, S. P., L. M. McMurry, D. C. Hooper, J. S. Wolfson, and S. B. Levy. 1989. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Eschenchia coli selected by tetracychne or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother. 33:1318-1325.
7. Cullen, M. E., A. W. Wyke, R. Kuroda, and L. M. Fisher. 1989. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-qumolones. Antimicrob Agents Chemother. 33:886-894.
8. Ferrero, L., B. Cameron, and J. Crouzet. 1995. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother. 39:1554-1558.
9. Ferrero, L., B. Cameron, B. Manse, D. Lagneaux, J. Crouzet, A. Famechon, and F. Blanche. 1994. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Mol. Microbiol. 13:641-653.
10. Goswitz, J. J., K. E. Willard, C. E. Fasching, and L. R. Peterson. 1992. Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymcrase chain reaction and automated direct DNA sequencing. Antimicrob. Agents Chemother. 36:1166-1169.
11. Hallett, P., and A. Maxwell. 1991. Novel quinolone resistance mutations of Escherichia coli DNA gyrase A protein enzymatic analysis of the mutant proteins. Antimicrob. Agents Chemother. 35:335-340.
12. Hane, M. W., and T. H. Wood. 1969 Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies. J Bacteriol. 99: 238-241.
13. Heisig, P. 1993. High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes. J. Antimicrob. Chemother. 32:367-377.
14. Heisig, P., S. Bagel, and V. Hullen. Personal communication
15. Heisig, P., B. Kratz, E. Halle, Y. Gräser, M. Altwegg, W. Rabsch, and J.-P. Faber. 1995 Identification of DNA gyrase A mutations in ciprofloxacinresistant isolates of Salmonella typhimunum from men and cattle in Germany Miciob Drug Resistance 1:211-218.
16. Heisig, P., H. Schedletzky, and H. Falkenstein-Paul. 1993. Mutations in the gyrA gene of a high-level fluoroquinolone-resistant clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 37:696-701.
17. Heisig, P., and R. Tschomy. 1994. Characterization of fluoroquinolone-resistant mutants of Escherichia coli selected in vitro. Antimicrob. Agents Chemother 38:1284-1291.
18. Heisig, P., and B. Wiedemann. 1991. Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria Antimicrob. Agents Chemother. 35:2031-2036.
19. Hooper, D. C., and J. S. Wolfson (ed.). Quinolone antibacterial agents, 2nd ed., p. 97-118. American Society for Microbiology. Washington, D.C.
20. Hooper, D. C., J. S. Wolfson, M. A. Bozza, and E. Y. Ng. 1992. Genetics and regulation of outer membrane protein expression by quinolone resistance loci nfxB, nficC, and cfxB Antimicrob. Agents Chemother. 36:1151-1154.
21. Hoshino, K., A. Kitamura, I. Morrissey, K. Sato, J.-I. Kato, and H. Ikeda. 1994. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Antimicrob. Agents Chemother. 38: 2623-2627.
22. Ito, H., H. Yoshida, M. Bogaki-Shonai, T. Niga, H. Hattori, and S. Nakamura. 1994 Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrob. Agents Chemother. 38: 2014-2023.
23. Kato, J.-I., Y. Nishimura, S. Imamura, H. Niki, S. Hiraga, and H. Suzuki. 1990. New topoisomerase essential for chromosome segregation in E. coli. Cell 63:393-404.
24. Kato, J.-I., Y. Nishimura, M. Yamada, H. Suzuki, and Y. Hirota. 1988. Gene organization in the region containing a new gene involved in chromosome partition in Escherichia coli. J. Bacteriol. 170:3967-3977.
25. Kato, J.-I., H. Suzuki, and H. Ikeda. 1992. Purification and characterization of DNA topoisomerase IV in Escherichia coli. J. Biol. Chem. 267:25676-25684.
26. Khodursky, A. B., E. L. Zechiedrich, and N. R. Cozzarelli. 1996. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. USA 92:11801-11805.
27. López-Brea, M., and T. Alarcón. 1990. Isolation of fluoroquinolone-resistant Escherichia coli and Kiebsiella pneumoniae from an infected Hickman catheter. Eur. J Clin. Microbiol. Infect. Dis. 9:345-347.
28. Luttinger, A. L., A. L. Springer, and M. B. Schmid. 1990. A cluster of genes that affects nucleoid segregation in Salmonella typhimunum. New Biol. 3: 687-697.
29. Margerrison, E. E. C., R. Hopewell, and L. M. Fisher. 1992. Nucleotide sequence of the Staphylocuccus aureus gyrB-gyrA locus encoding the DNA gyrase A and B proteins. J. Bacteriol. 174:1596-1603.
30. Nakamura, S., M. Nakamura, T. Kojima, and H. Yoshida. 1989. GyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob Agents Chemother. 33:254-255.
31. National Committee for Clinical Laboratory Standards. 1985. Methods for dilution antimicrobial susceptibility tests for bacteria that grow acrobically. M7-A. Volume 5, no. 22. National Committee for Clinical Laboratory Standards, Villanova. Pa.
32. Orani, M., and L. M. Fisher. 1991. 4-Qumolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction Antimicrob. Agents Chemother. 35:387-389.
33. Ouabdesselam, S., D. C. Hooper, J. Tankovic, and C. J. Soussy. 1995. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations. Antimicrob. Agents Chemother. 39:1667-1670.
34. Peng, H., and K. J. Marians. 1993 Eschenchia coli topoisomerase IV. J. Biol. Chem. 268:24481-24490.
35. Rayna, F., M. Huesca, V. Gonzalez, and L. Y. Fuchs. 1995. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance. Antimicrob. Agents Chemother. 39:1621-1623.
36. Reece, R. J., and A. Maxwell. 1991 DNA gyrase: structure and function. Crit. Rev. Biochem. Mol. Biol. 26:335-375.
37. Ruiz, J., F. Marco, P. Goñi, F. Gallardo, J. Mensa, A. Trilla, T. Jimenez De Anta, and J. Vila. 1995. High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coli J Antimicrob. Chemother. 36:737-738.
38. Samhrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning, a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
39. Schmid, M. B. 1990. A locus affecting nucleoid segregation in Salmonella typhimurium. J. Bacteriol. 172:5416-5424
40. Springer, A. L., and M. B. Schmid. 1993. Molecular characterization of the Salmonella typhimurium parE gene. Nucleic Acids Res 21:1805-1809
41. Sreedharan, S., M. Oram, B. Jensen, L. R. Peterson, and L. M. Fisher. 1990. DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus. close similarity with quinolone resistance mutations in Eschenchia coli. J. Bacteriol 172:7260-7262.
42. Steck, T. R., and K. Drlica. 1984. Bacterial chromosome segregation, evidence for DNA gyrase involvement in decatenation Cell 36:1081-1088.
43. Swanberg, S. L., and J. C. Wang. 1987. Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase. J. Mol. Biol. 197:729-736.
44. Vila, J., J. Ruiz, F. Marco, A. Barcelo, P. Goñi, E. Giralt, and T. Jimenez De Anta. 1994 Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob. Agents Chemother. 38:2477-2479.
45. Willmott, C. J. R, and A. Maxwell. 1993. A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex. Antimicrob. Agents Chemother. 37:126-127.
46. Wyckoff, E, D. Natalie, J. M. Nolan, M. Lee, and T.-S. Hsieh. 1989. Structure of the Drosophila DNA topoisomerase II gene: nucleotide sequence and homology among DNA topoisomerases II. J. Mol. Biol. 205:1-13.
47. Yamagishi, J.-I., H. Yoshida, M. Yamayoshi, and S. Nakamura. 1986. Nalidtxic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol. Gen. Genet. 204:367-373.
48. Yanish-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119
49. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
50. Yoshida, H., M. Bogaki, M. Nakamura, L. M. Yamanaka, and S. Nakamura. 1991 Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother 35:1647-1650.
51. Yoshida, H, M. Nakamura, M. Bogaki, H. Ito, T. Kojima, H. Hattori, and S. Nakamura. 1993. Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob. Agents Chemother. 37:839-845.